Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)
暂无分享，去创建一个
G. Thomas | V. Mathur | B. R. Tammelin | G. Schiffman | R. Marquez | D. L. Rice | D. Milikien | Vandana S. Mathur | Douglas A. Milikien | George L. Schiffman